ASSESSING THE RISK OF POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY COMPLICATIONS IN TYPE 2 DIABETICS ON GLP-1 AGONISTS: A MULTICENTER ANALYSIS - 14/06/24
Doi : 10.1016/j.gie.2024.04.1700
1199
Understanding and Minimizing ERCP Related Adverse Events in 2024
El texto completo de este artículo está disponible en PDF.Esquema
© 2024
Vol 99 - N° 6S
P. AB680 - juin 2024 Regresar al número
Artículo precedente
- ADVERSE EVENTS OF SELF-EXPANDABLE METAL STENT PLACEMENT FOR MALIGNANT DISTAL BILIARY OBSTRUCTION CAUSED BY PANCREATIC CANCER: A LARGE MULTICENTER STUDY
- Takashi Tamura, Takuo Yamai, Norimitsu Uza, Tomoaki Yamasaki, Atsuhiro Masuda, Hirotsugu Maruyama, Minoru Shigekawa, Takeshi Ogura, Katsutoshi Kuriyama, Masanori Asada, Hisakazu Matsumoto, Mamoru Takenaka, Koichiro Mandai, Yui Osaki, Kengo Matsumoto, Tsuyoshi Sanuki, Hideyuki Shiomi, Yosuke Yamagata, Toshifumi Doi, Osamu Inatomi, Tomoya Emori, Fumihiko Nakanishi, Masaaki Shimatani, Satoshi Asai, Seji Fujigaki, Masayuki Kitano
- ENDOSCOPIC VERSUS SURGICAL VERSUS CONSERVATIVE MANAGEMENT FOR TYPE 2 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PERFORATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
- Dushyant Singh Dahiya, Yash Shah, Sahib Singh, Bhanu Siva Mohan Pinnam, Saurabh Chandan, Hassam Ali, Manesh Kumar Gangwani, Sanket Basida, Daryl Ramai, Andrew Canakis, Daksh Ahluwalia, Erik Holzwanger, Mohammad Al-Haddad, Neil Sharma, Amit Rastogi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?